Abstract
Objectives
To investigate the clinical characteristics of Bechet’s disease (BD) with respect to gender and age in China.
Method
Clinical data of 489 BD patients admitted to Peking Union Medical College Hospital (PUMCH) and registered by the BD registry database established by PUMCH from March 2014 to January 2019 were collected and analyzed in this study. Demographics, medical histories, clinical manifestations, laboratory test results, imaging findings, assessment of disease activity, treatment regimen, as well as the outcomes were reviewed.
Results
A total of 489 BD patients were included in this study, among them 286 males (58.5%) and 203 females (41.5%) with a male-to-female ratio of 1.41 and a median age of 34 years (interquartile range 28–44 years old). The results revealed that ocular lesions (P = 0.005), vascular lesions(P < 0.001), pseudofolliculitis (P < 0.001), and positive pathergy test (P = 0.002) were more commonly found in males, while genital ulceration was more prevalent in females (P < 0.001). Vascular lesions (P = 0.024) and gastrointestinal ulcers (P = 0.010) were more common in BD patients after the age of 40, while pseudofolliculitis was more common in patients under the age of 40 (P = 0.004) and ocular lesions (P = 0.017) occurred mainly in patients under the age of 35. Male predominance of ocular involvement was more apparent in their third decades (Padjusted< 0.006), while vascular lesions were prominently presented in male patients at the age of 30–40 (Padjusted= 0.006). Female predominance of genital ulcers was observed in patients at the age of 30–40 (Padjusted< 0.006).
Conclusions
The clinical characteristics of BD were different with respect to gender and age.
Key Points • Ocular and vascular lesions, pseudofolliculitis, and positive pathergy test were more common in male BD patients. • Genital ulceration showed female predominance in BD patients. • Vascular lesions and gastrointestinal ulcers were more common in older BD patients. • Pseudofolliculitis and ocular lesions occurred mainly in younger BD patients. |
Similar content being viewed by others
Change history
09 June 2020
The original version of this article, unfortunately, contained an error. The following Funding information was incomplete in the original publication; the authors have requested that this be noted
References
Sakane T, Nishikawa M (1993) Behcet’s disease. N Engl J Med 341:416–420
Kim JN, Kwak SG, Choe J-Y, Kim S-K (2017) The prevalence of Behçet’s disease in Korea: data from Health Insurance Review and Assessment Service from 2011 to 2015. Clin Exp Rheumatol 35:38–42
Madanat WY, Alawneh KM, Smadi MM, Saadeh SS, Yazici H (2017) The prevalence of Behçet’s disease in the north of Jordan: a hospital-based epidemiological survey. Clin Exp Rheumatol 35(Suppl 108):51–54
Zhuoli Z, Jinmin P, Xiaomeng H, Yi D (2007) The meta-analysis of 1996 patients with Behcet’s disease. Med J Beijing 29:10–12
Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y (2011) Behcet disease: evolution of clinical manifestations. Medicine 90:125
Yazici H, Hamuryudan V, Hizli N, Yurdakul S, Mat C, Dimitriyadis I (1996) The ten-year mortality in Behcet’s syndrome. Br J Rheumatol 35:139–141
Bonitsis NG, Luong Nguyen LB, Lavalley MP, Papoutsis N, Altenburg A, Kötter I et al (2015) Gender-specific differences in Adamantiades-Behçet’s disease manifestations: an analysis of the German registry and meta-analysis of data from the literature. Rheumatology 54:121
Ishido T, Horita N, Takeuchi M, Kawagoe T, Shibuya E, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Ishigatsubo Y, Takeno M, Kurosawa M, Kaneko T, Mizuki N (2017) Clinical manifestations of Behçet’s disease depending on sex and age: results from Japanese nationwide registration. Rheumatology 56:1918–1927
Davatchi F, Chams-Davatchi C, Shams H, Nadji A, Faezi T, Akhlaghi M, Sadeghi Abdollahi B, Ashofteh F, Ghodsi Z, Mohtasham N, Shahram F (2016) Adult Behcet’s disease in Iran: analysis of 6075 patients. Int J Rheum Dis 19:95–103
Ugurlu N, Bozkurt S, Bacanli A, Akman-Karakas A, Uzun S, Alpsoy E (2015) The natural course and factors affecting severity of Behçet’s disease: a single-center cohort of 368 patients. Rheumatol Int 35:2103–2107
Khabbazi A, Noshad H, Shayan FK, Kavandi H, Hajialiloo M, Kolahi S (2018) Demographic and clinical features of Behcet’s disease in Azerbaijan. Int J Rheum Dis 21:1114–1119
Salvarani C, Pipitone N, Catanoso MG, Cimino L, Tumiati B, Macchioni P, Bajocchi G, Olivieri I, Boiardi L (2007) Epidemiology and clinical course of Behçet’s disease in the Reggio Emilia area of northern Italy: a seventeen-year population-based study. Arthritis Rheum 57:171–178
Sharquie KE, Al-Rawi Z, Hatem A, Al-Araji A (2002) The influence of age of onset and patient’s sex on the prevalence of clinical manifestations of Behcet’s disease in Iraqi patients. Ann Saudi Med 22:239–241
Hamzaoui A, Jaziri F, Ben ST, Said IBGF, Lamloum M, Smiti KM et al (2014) Comparison of clinical features of Behcet disease according to age in a Tunisian cohort. Acta Med Iran 52:748
Zhang Z, He F, Shi Y (2013) Behcet’s disease seen in China: analysis of 334 cases. Rheumatol Int 33:645–648
Shang Y, Han S, Li J, Ren Q, Song F, Chen H (2009) The clinical feature of Behçet’s disease in Northeastern China. Yonsei Med J 50:630–636
Wang LY, Zhao DB, Gu J, Dai SM (2010) Clinical characteristics of Behcet’s disease in China. Rheumatol Int 30:1191–1196
Geng L, Ohno S, Wang YH, Higuchi M (1985) Clinical observations on Behcet’s disease in Tianjin, China. Jpn J Ophthalmol 29:310–314
Wechsler B, Davatchi F, Mizushima Y, Hamza M, Dilsen N, Kansu E et al (1990) International study group for Behçet’s disease. Lancet 335:1078–1080
Davatchi F, Assaad-Khalil S, Calamia KT, Crook JE, Sadeghi-Abdollahi B, Schirmer M et al (2014) The international criteria for Behcet’s disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28:338–347
Mar S, Rocha VB, Garcia LC (2017) Behçet’s disease: review with emphasis on dermatological aspects. An Bras Dermatol 92:452–464
Seema K, Alan S, Gulsen AD, Saeed B, Afshin BH, Constantinescu CS et al (2013) Diagnosis and management of Neuro-Behcet’s disease: international consensus recommendations. J Neurol 333:e720–e720
Chun L (2017) Reclassification of age groups and their implications. Popul Res 41:16–25
Davatchi F, Chams-Davatchi C, Shams H, Shahram F, Nadji A, Akhlaghi M et al (2016) Behcet's disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev Clin Immunol 13:57
Khairallah M, Accorinti M, Muccioli C, Kahloun R, Kempen JH (2012) Epidemiology of Behçet disease. Ocul Immunol Inflamm 20:324
Kuralseyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V et al (2003) The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 82:60–76
Yazici H, Pazarli H, Yurdakul S, Ozyazgan Y, Ersanli M (1984) Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behcet’s syndrome. Ann Rheum Dis 43:783-789
Acknowledgments
We thank the health professional staff from the Department of Rheumatology & Clinical Immunology, Peking Union Medical College Hospital and the patients for their participation in this study.
Funding
This study was supported by grants from the National Key Research and Development Program: “Precise Medical Research” [2016YFC0906201], National Natural Science Foundation of China [81871299], the Chinese National Key Technology R&D Program, Ministry of Science and Technology [2017YFC0907601].
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Disclosures
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, C., Li, L., Wu, X. et al. Clinical manifestations of Behçet’s disease in a large cohort of Chinese patients: gender- and age-related differences. Clin Rheumatol 39, 3449–3454 (2020). https://doi.org/10.1007/s10067-020-05026-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-020-05026-2